A new study conducted by researchers at the University of California has found that it is not just one, but a combination of two abnormal factors, that cause adult acne or rosacea.
Adult acne is a common condition which affects fair-skinned people of mostly north-western European descent. It begins as erythema (flushing and redness) on the central face and across the cheeks, nose, or forehead but can also less commonly affect the neck and chest.
Home Remedies for Acne | Pimples
Home remedies offer you an herbal and natural method to treat acne effectively. It also explains the preparation, using basic household ingredients and dosage to get rid of the ailment.
Advertisement
It is linked with a type of bacteria, and antibiotics are prescribed to treat its symptoms. It, however, worsens over time.
During the study, Richard L. Gallo and his colleagues first observed in the laboratory that small proteins of the body's host defence system called anti-microbial peptides caused the exact symptoms like redness, an increase in visible blood vessels, bumps or pimples, that rosacea did.
"When we then looked at patients with the disease, every one of them had far more peptides than normal." Nature magazine quoted Gallo as saying.
The researchers examined the source of these molecules to know why these patients had abnormal peptides.
The precursor form of these peptides, called cathelicidin, is known to guard the skin against infection. A deficiency of cathelicidin correlates with increased infection in other skin diseases.
The study found the opposite in rosacea patients, as excessive cathelicidin of a different form was present in their skin.
Rosacea patients also had high levels of enzymes called stratum corneum tryptic enzymes (SCTE). These enzymes turned the precursor into the disease-causing peptide.
The inflammation in the skin of the mice increased when the researches injected them with cathelicidin peptides, indicating that these abnormalities can cause the disease.
"Too much SCTE and too much cathelicidin leads to the abnormal peptides that cause the symptoms of this disease. Antibiotics tend to alleviate the symptoms of rosacea in patients because some of them work to inhibit these enzymes. Our findings may modify the therapeutic approach to treating rosacea, since bacteria aren't the right target," Gallo said.
Source: ANI
LIN/J
Advertisement
"When we then looked at patients with the disease, every one of them had far more peptides than normal." Nature magazine quoted Gallo as saying.
The researchers examined the source of these molecules to know why these patients had abnormal peptides.
The precursor form of these peptides, called cathelicidin, is known to guard the skin against infection. A deficiency of cathelicidin correlates with increased infection in other skin diseases.
The study found the opposite in rosacea patients, as excessive cathelicidin of a different form was present in their skin.
Rosacea patients also had high levels of enzymes called stratum corneum tryptic enzymes (SCTE). These enzymes turned the precursor into the disease-causing peptide.
The inflammation in the skin of the mice increased when the researches injected them with cathelicidin peptides, indicating that these abnormalities can cause the disease.
"Too much SCTE and too much cathelicidin leads to the abnormal peptides that cause the symptoms of this disease. Antibiotics tend to alleviate the symptoms of rosacea in patients because some of them work to inhibit these enzymes. Our findings may modify the therapeutic approach to treating rosacea, since bacteria aren't the right target," Gallo said.
Source: ANI
LIN/J
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.